- Global Pharma News & Resources

Tricida to Report Third Quarter Financial Results and Host Conference Call and Webcast on Thursday, November 8, 2018

Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its third quarter 2018 financial results after the close of market on Thursday, November 8, 2018. Tricida will host a conference call and webcast at 5:00 pm Eastern Time to discuss its financial results and business progress. The call or webcast may be accessed as follows:

Tricida Third Quarter 2018 Conference Call
Thursday, November 8, 2018

5:00 pm Eastern Time


Dial-in: (877) 377-5478
International: (629) 228-0740
Conference ID: 7553409

A replay of the webcast will be available on Tricida’s website approximately two hours following the completion of the call and will be available for up to 90 days following the presentation.

About Tricida

Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of TRC101, a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease. For more information about Tricida, please visit the company’s website at

View source version on

Editor Details

Last Updated: 01-Nov-2018